약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 4.

Table. 4.

The number of adverse events of baricitinib

All adverse events
number (%)
Respiratory system disorders 17 (15.0)
Pneumonia 6 (5.3)
Pharyngitis 3 (2.7)
Upper respiratory tract infection 2 (1.8)
Dyspnoea 2 (1.8)
Body as a whole-general disorders 16 (14.2)
Asthenia 3 (2.7)
Malaise 2 (1.8)
Oedema 2 (1.8)
Fatigue 2 (1.8)
Gastro-intestinal system disorders 15 (13.3)
Dyspepsia 6 (5.3)
Diarrhoea 3 (2.7)
Vomiting 2 (1.8)
Urinary system disorders 10 (8.8)
Pyelonephritis 3 (2.7)
Urinary tract infection 2 (1.8)
Face oedema 2 (1.8)
Skin and appendages disorders 9 (8.0)
Alopecia 4 (3.5)
Rash 3 (2.7)
Central & peripheral nervous system disorders 8 (7.1)
Dizziness 6 (5.3)
Metabolic and nutritional disorders 7 (6.2)
Weight increase 6 (5.3)
Resistance mechanism disorders 7 (6.2)
Herpes zoster 5 (4.4)
Yakhak Hoeji 2022;66:49-57 https://doi.org/10.17480/psk.2022.66.2.49
© 2022 Yakhak Hoeji